2025 annual financial data
OnKure Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -62,950,000 USD and net income was -59,517,000 USD.
Operating cash flow was -51,828,000 USD.
Get free OnKure Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -62,950,000 USD
- Net income
- -59,517,000 USD
- Operating cash flow
- -51,828,000 USD